Moheb Nabil Boktor

Moheb Boktor practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Moheb Boktor's NPI, 1811187354, was assigned on July 31, 2007. Moheb Boktor graduated from Ain Shams University Faculty of Medicine in 2001. Moheb Boktor holds Texas license R9190.

Moheb Boktor's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Moheb Boktor's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. The medical group on file is University of Texas Southwestern Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Moheb Boktor practices. Vendor and product names are available with a free account.

Gastroenterology is Moheb Boktor's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Moheb Boktor is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Moheb Boktor's licenses on file in 2 states: Texas and Louisiana.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding and intestinal diverticulosis among the conditions Moheb Boktor treats.

CMS data shows 283 Medicare services from Moheb Boktor across 11 procedure codes in 2024, for 226 Medicare patients. Medicare paid $28,247 for them.

CMS counts 226 Medicare patients who saw Moheb Boktor in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Moheb Boktor's median patient age at 52, with 54% women.

In 2024, Moheb Boktor wrote 382 Medicare Part D claims for 209 patients. 68% of them were for generic drugs. CMS names the drug for 273 of them, across 7 drugs with 11 or more claims each, at $873,432 in total drug cost. In 2023, CMS named 200 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Moheb Boktor for performance year 2024, reported as part of a group. Moheb Boktor accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Moheb Boktor as offering telehealth. CMS counts 46 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Moheb Boktor, more than 62% of the clinicians it reports for that procedure.

Dmand AI links 27 papers to Moheb Boktor, published from 2010 to 2024. 2019 was the busiest year, with 5. The most frequent topics are Inflammatory Bowel Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors and Intestines. Moheb Boktor has published most often in Pathophysiology. Moheb Boktor's most frequent co-authors are Paul Alexander Jordan, MD, James Daniel Morris, MD and Sudha Pandit, MD.

CMS Open Payments shows 223 general payments to Moheb Boktor from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $1,916. It also lists 1 research payment totaling $15 in 2017.

Moheb Boktor graduated from Ain Shams University Faculty of Medicine in 2001.

Moheb Boktor is in network with 20 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.